Literature DB >> 2920950

Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer.

J F Barter1, S J Soong, H M Shingleton, K D Hatch, J W Orr.   

Abstract

Fifty patients with cervical cancer were treated with radical hysterectomy and lymphadenectomy followed by postoperative radiation therapy for high risk factors (nodal metastases, lymphvascular space invasion, close or involved margins) at the University of Alabama at Birmingham Medical Center from 1969 to 1984. Fifteen (30%) of the patients treated had serious complications, 8 (16%) requiring an operation, and 1 (2%) dying as a result of treatment-related problems. This combined modality approach is associated with significant complications.

Entities:  

Mesh:

Year:  1989        PMID: 2920950     DOI: 10.1016/0090-8258(89)90627-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

Review 1.  Antiangiogenics and immunotherapies in cervical cancer: an update and future's view.

Authors:  Daniela Luvero; Francesco Plotti; Salvatore Lopez; Giuseppe Scaletta; Stella Capriglione; Roberto Montera; Gianina Antonelli; Sara Ciuffreda; Raffaella Carassiti; Alice Oliveti; Roberto Angioli
Journal:  Med Oncol       Date:  2017-05-05       Impact factor: 3.064

2.  Evaluation of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer: a single-institution experience.

Authors:  Kaoru Okugawa; Hideaki Yahata; Kenzo Sonoda; Keisuke Kodama; Hiroshi Yagi; Tatsuhiro Ohgami; Masafumi Yasunaga; Ichiro Onoyama; Eisuke Kaneki; Kazuo Asanoma; Hiroaki Kobayashi; Kiyoko Kato
Journal:  Int J Clin Oncol       Date:  2020-09-03       Impact factor: 3.402

3.  Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidity.

Authors:  Arne Gruen; Thabea Musik; Christhardt Köhler; Jürgen Füller; Thomas Wendt; Carmen Stromberger; Volker Budach; Achim Schneider; Simone Marnitz
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

4.  Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.

Authors:  Daniela Luvero; Francesco Plotti; Alessia Aloisi; Stella Capriglione; Roberto Ricciardi; Andrea Miranda; Salvatore Lopez; Giuseppe Scaletta; Giovanna De Luca; Pierluigi Benedetti-Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2016-08-30       Impact factor: 3.064

5.  Radiation colitis and proctitis.

Authors:  Gregory D Kennedy; Charles P Heise
Journal:  Clin Colon Rectal Surg       Date:  2007-02

6.  Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioning.

Authors:  Carmen Stromberger; Yves Kom; Michael Kawgan-Kagan; Tristan Mensing; Ulrich Jahn; Achim Schneider; Volker Budach; Christhardt Köhler; Simone Marnitz
Journal:  Radiat Oncol       Date:  2010-07-02       Impact factor: 3.481

7.  Treatment options in recurrent cervical cancer (Review).

Authors:  Angiolo Gadducci; Roberta Tana; Stefania Cosio; Luca Cionini
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

Review 8.  Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.

Authors:  Astrid Baalbergen; Yerney Veenstra; Lukas Stalpers
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

9.  Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.

Authors:  Wenze Sun; Tao Wang; Fan Shi; Jiquan Wang; Juan Wang; Beina Hui; Yingbing Zhang; Jinli Lu; Hongwei Chen; Zi Liu
Journal:  BMC Cancer       Date:  2015-05-04       Impact factor: 4.430

10.  Androgen deprivation modulates the inflammatory response induced by irradiation.

Authors:  Chun-Te Wu; Wen-Cheng Chen; Paul-Yang Lin; Shuen-Kuei Liao; Miao-Fen Chen
Journal:  BMC Cancer       Date:  2009-03-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.